BIO-key International (NASDAQ:BKYI – Get Free Report) was upgraded by equities research analysts at Wall Street Zen to a “hold” rating in a note issued to investors on Saturday, Wall Street Zen reports.
Other equities research analysts have also recently issued reports about the stock. Zacks Research raised shares of BIO-key International to a “hold” rating in a research report on Thursday, August 6th. Weiss Ratings reissued a “sell (e+)” rating on shares of BIO-key International in a report on Thursday, October 15th. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Reduce”.
View Our Latest Research Report on BKYI
BIO-key International Price Performance
Shares of NASDAQ:BKYI opened at $3.39 on Friday. The firm’s 50 day moving average price is $2.59 and its 200 day moving average price is $3.95. The stock has a market cap of $6.92 million, a price-to-earnings ratio of -0.82 and a beta of 0.50. BIO-key International has a fifty-two week low of $1.55 and a fifty-two week high of $19.70.
BIO-key International (NASDAQ:BKYI – Get Free Report) last issued its quarterly earnings results on Thursday, August 13th. The technology company reported ($0.56) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.82) by $0.26. BIO-key International had a negative net margin of 50.01% and a negative return on equity of 67.31%. The company had revenue of $1.92 million during the quarter, compared to the consensus estimate of $1.80 million. On average, equities analysts anticipate that BIO-key International will post -1.62 EPS for the current year.
About BIO-key International
BIO-key International, Inc (NASDAQ: BKYI) develops biometric identity and access-management solutions. Its technology enables organizations to authenticate users through fingerprints and other biometric credentials, helping replace or supplement passwords while supporting secure access to applications, networks and devices.
The company’s offerings include biometric readers and software, as well as identity and access-management platforms such as PortalGuard and WEB-key. These products are designed to support multifactor authentication, single sign-on, password management and identity verification across on-premises and cloud-based environments.
BIO-key serves businesses, government agencies, educational institutions and other organizations that require secure user authentication.
Further Reading
- Five stocks we like better than BIO-key International
- Newmont’s Record Quarter Shows Why Gold’s Floor Is the Real Story
- Albemarle Upgrade: Can Energy Storage Recharge Lithium’s Leader?
- Consumer Staples Are Up 12% This Year—These 3 Beverage Stocks Are Leading the Way
- Can Planet Fitness Get Its Growth Back in Shape?
Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.
